The experts in what? If I wanted to discuss cancer therapies and their potential, I would not go to market maker or trader as my first port of call. My question is, is the product derived from good science with the potential for success in its chosen field, based upon current facts and data. The market is looking at how long until they make some money and if it’s not imminent the value of the stock is low. Make up your own mind which way you go, but if you are in a biotech stock looking to become a millionaire in the next 6 months, when it has phase I and II drugs, my advice would be stop smoking that stuff it’s not doing you any good.
PTX Price at posting:
2.7¢ Sentiment: Buy Disclosure: Held
